EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy



Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy



British Journal of Dermatology 145(3): 415-421, September



Background: Topical immunotherapy with a contact allergen is effective in alopecia areata (AA). However, the mechanism of the effect is still unknown, and pretreatment prediction of the outcome of therapy in each patient remains difficult. Objectives: To predict the clinical effect of this therapy in AA patients, we investigated the relationship between clinical responses to topical immunotherapy and in vitro proliferative responses of peripheral blood mononuclear cells (PBMC) to T-cell stimulants. Methods: PBMC were taken from 67 AA patients before or during diphenylcyclopropenone immunotherapy and from 14 healthy controls, and proliferative responses to phytohaemagglutinin and staphylococcal enterotoxin B were evaluated by measuring (3H)-thymidine incorporation. Results: PBMC from the AA patients with a good clinical response to immunotherapy showed a normal level of proliferation, whereas PBMC from the poor responders showed a markedly suppressed proliferative response and interleukin (IL)-2 production, but increased IL-4 production compared with the controls. Conclusions: The proliferative response of PBMC to T-cell stimulants may be one of the indicators of the clinical effect of topical immunotherapy for AA.

(PDF emailed within 0-6 h: $19.90)

Accession: 010804411

Download citation: RISBibTeXText

PMID: 11531830

DOI: 10.1111/j.1365-2133.2001.04398.x



Related references

Immuno therapy of alopecia areata increase of thymus derived cell sub populations in the peripheral blood of patients with alopecia areata treated by topical application of 1 chloro 2 4 dinitro benzene. Archives of Dermatological Research 266(3): 323-326, 1979

Study of Th1/Th2 balance in peripheral blood mononuclear cells of patients with alopecia areata. Acta Microbiologica et Immunologica Hungarica 62(3): 275-285, 2015

Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. British Journal of Dermatology 166(2): 226-273, 2012

Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata. Bba Clinical 5(): 134-142, 2016

In vivo levels of IL-4, IL-10, TGF-beta 1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Archives of Dermatological Research 298(8): 397-401, 2007

In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Archives of Dermatological Research 298(8): 397-401, 2006

Regulatory effect of procyanidins on the expressions of interferon-gamma, interleukin-12 and transcription factor T-bet mRNA in peripheral blood mononuclear cell of patients with alopecia areata. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 28(10): 900-902, 2010

Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis. Journal of Investigative Dermatology 114(2): 281-288, 2000

Growth inhibition in human microendothelial cells by proinflammatory cytokines and proapoptotic molecules released from peripheral mononuclear blood cells in alopecia areata. Journal of Investigative Dermatology Symposium Proceedings 8(1): 137, June, 2003

Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester. Archives of Dermatology 133(4): 539-540, 1997

Serum cortisol and peripheral blood mononuclear cell glucocorticoid receptor mRNA expression in severe alopecia areata with liver-kidney deficiency syndrome. Nan Fang Yi Ke Da Xue Xue Bao 32(2): 230-233, 2013

The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Experimental Dermatology 13(7): 435-444, 2004

Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design. Journal of the European Academy of Dermatology and Venereology 26(4): 503-507, 2012

Increase in the activated (HLA-DR+) T-cells in the peripheral blood lymphocyte of patients with alopecia areata. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 98(3): 355-360, 1988